Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

laurus generics gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmazac s.a. - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+1000 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmazac s.a. - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+850 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

reddy holding gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 100 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

reddy holding gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

tiefenbacher gmbh - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+850 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

viatris limited - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 25 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmathen s.a. - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 25 mg

Европейски съюз - датски - EMA (European Medicines Agency)

eli lilly nederland b.v. - dulaglutide - diabetes mellitus, type 2 - drugs used in diabetes, blood glucose lowering drugs, excl. insulins - trulicity is indicated for the treatment of patients 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for undersøgelsens resultater med hensyn til kombinationer, effekt på glykæmisk kontrol og hjerte-kar-hændelser, og de befolkninger, der studerede, se afsnit 4. 4, 4. 5 og 5.

Европейски съюз - датски - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.